Application 020758
- Type
- NDA
- Sponsor
- SANOFI AVENTIS US
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | AVALIDE | HYDROCHLOROTHIAZIDE; IRBESARTAN | TABLET;ORAL | 12.5MG;75MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | Yes | No |
| 002 | AVALIDE | HYDROCHLOROTHIAZIDE; IRBESARTAN | TABLET;ORAL | 12.5MG;150MG | Yes | Yes |
| 003 | AVALIDE | HYDROCHLOROTHIAZIDE; IRBESARTAN | TABLET;ORAL | 12.5MG;300MG | Yes | Yes |
| 004 | AVALIDE | HYDROCHLOROTHIAZIDE; IRBESARTAN | TABLET;ORAL | 25MG;300MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | Yes | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N020758-001 | AVALIDE | HYDROCHLOROTHIAZIDE; IRBESARTAN | 12.5MG;75MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1997-09-30 | |
| N020758-002 | AVALIDE | HYDROCHLOROTHIAZIDE; IRBESARTAN | 12.5MG;150MG | TABLET / ORAL | AB | RLD, RS | 1997-09-30 |
| N020758-003 | AVALIDE | HYDROCHLOROTHIAZIDE; IRBESARTAN | 12.5MG;300MG | TABLET / ORAL | AB | RLD, RS | 1998-08-31 |
| N020758-004 | AVALIDE | HYDROCHLOROTHIAZIDE; IRBESARTAN | 25MG;300MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 2005-03-15 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| N020758-002 | AB |
| N020758-003 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-18 06:07:40 | 2026-07 | N020758-001 | AVALIDE | 12.5MG;75MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1997-09-30 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N020758-002 | AVALIDE | 12.5MG;150MG | TABLET / ORAL | AB | RLD, RS | 1997-09-30 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N020758-003 | AVALIDE | 12.5MG;300MG | TABLET / ORAL | AB | RLD, RS | 1998-08-31 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N020758-004 | AVALIDE | 25MG;300MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 2005-03-15 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | N020758-001 | AVALIDE | 12.5MG;75MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1997-09-30 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N020758-002 | AVALIDE | 12.5MG;150MG | TABLET / ORAL | AB | RLD, RS | 1997-09-30 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N020758-003 | AVALIDE | 12.5MG;300MG | TABLET / ORAL | AB | RLD, RS | 1998-08-31 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N020758-004 | AVALIDE | 25MG;300MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 2005-03-15 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N020758-001 | AVALIDE | 12.5MG;75MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1997-09-30 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N020758-002 | AVALIDE | 12.5MG;150MG | TABLET / ORAL | AB | RLD, RS | 1997-09-30 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N020758-003 | AVALIDE | 12.5MG;300MG | TABLET / ORAL | AB | RLD, RS | 1998-08-31 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N020758-004 | AVALIDE | 25MG;300MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 2005-03-15 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | N020758-001 | AVALIDE | 12.5MG;75MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1997-09-30 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N020758-002 | AVALIDE | 12.5MG;150MG | TABLET / ORAL | AB | RLD, RS | 1997-09-30 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N020758-003 | AVALIDE | 12.5MG;300MG | TABLET / ORAL | AB | RLD, RS | 1998-08-31 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N020758-004 | AVALIDE | 25MG;300MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 2005-03-15 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N020758-001 | AVALIDE | 12.5MG;75MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1997-09-30 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N020758-002 | AVALIDE | 12.5MG;150MG | TABLET / ORAL | AB | RLD, RS | 1997-09-30 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N020758-003 | AVALIDE | 12.5MG;300MG | TABLET / ORAL | AB | RLD, RS | 1998-08-31 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N020758-004 | AVALIDE | 25MG;300MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 2005-03-15 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N020758-001 | AVALIDE | 12.5MG;75MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1997-09-30 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N020758-002 | AVALIDE | 12.5MG;150MG | TABLET / ORAL | AB | RLD, RS | 1997-09-30 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N020758-003 | AVALIDE | 12.5MG;300MG | TABLET / ORAL | AB | RLD, RS | 1998-08-31 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N020758-004 | AVALIDE | 25MG;300MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 2005-03-15 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N020758-001 | AVALIDE | 12.5MG;75MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1997-09-30 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N020758-002 | AVALIDE | 12.5MG;150MG | TABLET / ORAL | AB | RLD, RS | 1997-09-30 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N020758-003 | AVALIDE | 12.5MG;300MG | TABLET / ORAL | AB | RLD, RS | 1998-08-31 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N020758-004 | AVALIDE | 25MG;300MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 2005-03-15 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N020758-001 | AVALIDE | 12.5MG;75MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1997-09-30 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N020758-002 | AVALIDE | 12.5MG;150MG | TABLET / ORAL | AB | RLD, RS | 1997-09-30 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N020758-003 | AVALIDE | 12.5MG;300MG | TABLET / ORAL | AB | RLD, RS | 1998-08-31 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N020758-004 | AVALIDE | 25MG;300MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 2005-03-15 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N020758-001 | AVALIDE | 12.5MG;75MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1997-09-30 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N020758-002 | AVALIDE | 12.5MG;150MG | TABLET / ORAL | AB | RLD, RS | 1997-09-30 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N020758-003 | AVALIDE | 12.5MG;300MG | TABLET / ORAL | AB | RLD, RS | 1998-08-31 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N020758-004 | AVALIDE | 25MG;300MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 2005-03-15 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N020758-001 | AVALIDE | 12.5MG;75MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1997-09-30 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N020758-002 | AVALIDE | 12.5MG;150MG | TABLET / ORAL | AB | RLD, RS | 1997-09-30 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N020758-003 | AVALIDE | 12.5MG;300MG | TABLET / ORAL | AB | RLD, RS | 1998-08-31 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N020758-004 | AVALIDE | 25MG;300MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 2005-03-15 | d8e5a09893c0… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-18 06:07:40 | 2026-07 | N020758-002 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N020758-003 | AB | 1 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | N020758-002 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N020758-003 | AB | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N020758-002 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N020758-003 | AB | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | N020758-002 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N020758-003 | AB | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N020758-002 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N020758-003 | AB | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N020758-002 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N020758-003 | AB | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N020758-002 | AB | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N020758-003 | AB | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N020758-002 | AB | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N020758-003 | AB | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N020758-002 | AB | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N020758-003 | AB | 1 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N020758-002 | AB | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N020758-003 | AB | 1 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | N020758-002 | AB | 1 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | N020758-003 | AB | 1 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N020758-002 | AB | 1 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N020758-003 | AB | 1 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N020758-002 | AB | 1 | 301d65b070ca… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N020758-003 | AB | 1 | 301d65b070ca… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N020758-002 | AB | 1 | 1e350fbaab3a… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N020758-003 | AB | 1 | 1e350fbaab3a… |
| 2024-05-31 18:47 UTC | 2024-05 | N020758-002 | AB | 1 | 8072bd15b7f6… |
| 2024-05-31 18:47 UTC | 2024-05 | N020758-003 | AB | 1 | 8072bd15b7f6… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N020758-002 | AB | 1 | 5c6f7cd8ea54… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N020758-003 | AB | 1 | 5c6f7cd8ea54… |
| 2022-04-08 23:34 UTC | 2022-04 | N020758-002 | AB | 1 | 5d02ea3f76ae… |
| 2022-04-08 23:34 UTC | 2022-04 | N020758-003 | AB | 1 | 5d02ea3f76ae… |
| 2022-04-04 05:41 UTC | 2022-04 | N020758-002 | AB | 1 | 4b0b4de00fa7… |
| 2022-04-04 05:41 UTC | 2022-04 | N020758-003 | AB | 1 | 4b0b4de00fa7… |
| 2019-12-13 00:20 UTC | 2019-12 | N020758-002 | AB | 1 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | N020758-003 | AB | 1 | 74a2ff9319b5… |
| 2022-03-09 01:35 UTC | 2022-03 | N020758-002 | AB | 1 | bb7c543d1eb4… |
| 2022-03-09 01:35 UTC | 2022-03 | N020758-003 | AB | 1 | bb7c543d1eb4… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0024-5855 | Avalide | irbesartan and hydrochlorothiazide | sanofi-aventis U.S. LLC | NDA | Current |
| 0024-5855 | Avalide | irbesartan and hydrochlorothiazide | Sanofi-Aventis U.S. LLC | NDA | Current |
| 0024-5855 | Avalide | irbesartan and hydrochlorothiazide | Sanofi-Aventis U.S. LLC | NDA | Current |
| 0024-5855 | Avalide | irbesartan and hydrochlorothiazide | sanofi-aventis U.S. LLC | NDA | Current |
| 0024-5855 | Avalide | irbesartan and hydrochlorothiazide | Sanofi-Aventis U.S. LLC | NDA | Current |
| 0024-5855 | Avalide | irbesartan and hydrochlorothiazide | Sanofi-Aventis U.S. LLC | NDA | Current |
| 0024-5855 | Avalide | irbesartan and hydrochlorothiazide | Sanofi-Aventis U.S. LLC | NDA | Current |
| 0024-5855 | Avalide | irbesartan and hydrochlorothiazide | Sanofi-Aventis U.S. LLC | NDA | Current |
| 0024-5855 | Avalide | irbesartan and hydrochlorothiazide | Sanofi-Aventis U.S. LLC | NDA | Current |
| 0024-5856 | Avalide | irbesartan and hydrochlorothiazide | sanofi-aventis U.S. LLC | NDA | Current |
| 0024-5856 | Avalide | irbesartan and hydrochlorothiazide | Sanofi-Aventis U.S. LLC | NDA | Current |
| 0024-5856 | Avalide | irbesartan and hydrochlorothiazide | Sanofi-Aventis U.S. LLC | NDA | Current |
| 0024-5856 | Avalide | irbesartan and hydrochlorothiazide | sanofi-aventis U.S. LLC | NDA | Current |
| 0024-5856 | Avalide | irbesartan and hydrochlorothiazide | Sanofi-Aventis U.S. LLC | NDA | Current |
| 0024-5856 | Avalide | irbesartan and hydrochlorothiazide | Sanofi-Aventis U.S. LLC | NDA | Current |
| 0024-5856 | Avalide | irbesartan and hydrochlorothiazide | Sanofi-Aventis U.S. LLC | NDA | Current |
| 0024-5856 | Avalide | irbesartan and hydrochlorothiazide | Sanofi-Aventis U.S. LLC | NDA | Current |
| 0024-5856 | Avalide | irbesartan and hydrochlorothiazide | Sanofi-Aventis U.S. LLC | NDA | Current |
| 0955-1045 | Irbesartan and Hydrochlorothiazide | irbesartan and hydrochlorothiazide | Winthrop U.S. | NDA AUTHORIZED GENERIC | Current |
| 0955-1045 | Irbesartan and Hydrochlorothiazide | irbesartan and hydrochlorothiazide | Winthrop U.S. | NDA AUTHORIZED GENERIC | Current |
| 0955-1045 | Irbesartan and Hydrochlorothiazide | irbesartan and hydrochlorothiazide | Winthrop U.S. | NDA AUTHORIZED GENERIC | Current |
| 0955-1045 | Irbesartan and Hydrochlorothiazide | irbesartan and hydrochlorothiazide | Winthrop U.S. | NDA AUTHORIZED GENERIC | Current |
| 0955-1045 | Irbesartan and Hydrochlorothiazide | irbesartan and hydrochlorothiazide | Winthrop U.S. | NDA AUTHORIZED GENERIC | Current |
| 0955-1045 | Irbesartan and Hydrochlorothiazide | irbesartan and hydrochlorothiazide | Winthrop U.S. | NDA AUTHORIZED GENERIC | Current |
| 0955-1045 | Irbesartan and Hydrochlorothiazide | irbesartan and hydrochlorothiazide | Winthrop U.S. | NDA AUTHORIZED GENERIC | Current |
| 0955-1046 | Irbesartan and Hydrochlorothiazide | irbesartan and hydrochlorothiazide | Winthrop U.S. | NDA AUTHORIZED GENERIC | Current |
| 0955-1046 | Irbesartan and Hydrochlorothiazide | irbesartan and hydrochlorothiazide | Winthrop U.S. | NDA AUTHORIZED GENERIC | Current |
| 0955-1046 | Irbesartan and Hydrochlorothiazide | irbesartan and hydrochlorothiazide | Winthrop U.S. | NDA AUTHORIZED GENERIC | Current |
| 0955-1046 | Irbesartan and Hydrochlorothiazide | irbesartan and hydrochlorothiazide | Winthrop U.S. | NDA AUTHORIZED GENERIC | Current |
| 0955-1046 | Irbesartan and Hydrochlorothiazide | irbesartan and hydrochlorothiazide | Winthrop U.S. | NDA AUTHORIZED GENERIC | Current |
| 0955-1046 | Irbesartan and Hydrochlorothiazide | irbesartan and hydrochlorothiazide | Winthrop U.S. | NDA AUTHORIZED GENERIC | Current |
| 0955-1046 | Irbesartan and Hydrochlorothiazide | irbesartan and hydrochlorothiazide | Winthrop U.S. | NDA AUTHORIZED GENERIC | Current |
| 71335-1392 | Irbesartan and Hydrochlorothiazide | irbesartan and hydrochlorothiazide | Bryant Ranch Prepack | NDA AUTHORIZED GENERIC | Current |
| 71335-1392 | Irbesartan and Hydrochlorothiazide | irbesartan and hydrochlorothiazide | Bryant Ranch Prepack | NDA AUTHORIZED GENERIC | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 83043 | SUPPL | 2025-08-05 |
| 83034 | SUPPL | 2025-08-04 |
| 68611 | SUPPL | 2021-09-14 |
| 68601 | SUPPL | 2021-09-13 |
| 67468 | SUPPL | 2021-05-12 |
| 67458 | SUPPL | 2021-05-12 |
| 65655 | SUPPL | 2020-12-21 |
| 65601 | SUPPL | 2020-12-16 |
| 64432 | SUPPL | 2020-08-27 |
| 64431 | SUPPL | 2020-08-27 |
| 64384 | SUPPL | 2020-08-24 |
| 55141 | SUPPL | 2018-08-09 |
| 54947 | SUPPL | 2018-07-23 |
| 48972 | SUPPL | 2017-07-13 |
| 48965 | SUPPL | 2017-07-13 |
| 35288 | SUPPL | 2016-02-18 |
| 25721 | SUPPL | 2016-02-09 |
| 3279 | SUPPL | 2014-06-02 |
| 35287 | SUPPL | 2014-05-30 |
| 3278 | SUPPL | 2012-10-29 |
| 13355 | SUPPL | 2012-10-26 |
| 35285 | SUPPL | 2012-02-17 |
| 25719 | SUPPL | 2012-02-13 |
| 35286 | SUPPL | 2012-01-23 |
| 25720 | SUPPL | 2012-01-23 |
| 25718 | SUPPL | 2011-06-09 |
| 3277 | SUPPL | 2011-06-09 |
| 35284 | SUPPL | 2011-06-06 |
| 35283 | SUPPL | 2011-06-06 |
| 35282 | SUPPL | 2010-09-10 |
| 25717 | SUPPL | 2010-09-09 |
| 20913 | ORIG | 2009-09-01 |
| 25716 | SUPPL | 2007-11-19 |
| 13354 | SUPPL | 2007-11-19 |
| 35281 | SUPPL | 2006-04-25 |
| 3276 | SUPPL | 2006-04-25 |
| 25715 | SUPPL | 2005-11-30 |
| 44463 | SUPPL | 2005-05-05 |
| 41665 | SUPPL | 2005-05-05 |
| 44464 | SUPPL | 2005-05-03 |
| 41666 | SUPPL | 2005-05-03 |
| 20916 | SUPPL | 2005-05-03 |
| 41667 | SUPPL | 2005-04-27 |
| 20917 | SUPPL | 2005-04-27 |
| 3275 | SUPPL | 2005-03-18 |
| 20915 | SUPPL | 2004-05-27 |
| 20914 | SUPPL | 1998-08-31 |